JP2018193405A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018193405A5 JP2018193405A5 JP2018171794A JP2018171794A JP2018193405A5 JP 2018193405 A5 JP2018193405 A5 JP 2018193405A5 JP 2018171794 A JP2018171794 A JP 2018171794A JP 2018171794 A JP2018171794 A JP 2018171794A JP 2018193405 A5 JP2018193405 A5 JP 2018193405A5
- Authority
- JP
- Japan
- Prior art keywords
- heterocyclyl
- haloalkyl
- heteroaryl
- alkynyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 18
- 125000006647 (C3-C15) cycloalkyl group Chemical group 0.000 claims 18
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 18
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 18
- 125000003118 aryl group Chemical group 0.000 claims 18
- 125000001072 heteroaryl group Chemical group 0.000 claims 18
- 125000000623 heterocyclic group Chemical group 0.000 claims 18
- 125000006545 (C1-C9) alkyl group Chemical group 0.000 claims 16
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 7
- 125000004414 alkyl thio group Chemical group 0.000 claims 6
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 125000001475 halogen functional group Chemical group 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 1
- 239000012320 chlorinating reagent Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019137759A JP6906021B2 (ja) | 2015-07-06 | 2019-07-26 | Ｃｏｔモジュレーターおよびその使用方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562189158P | 2015-07-06 | 2015-07-06 | |
| US62/189,158 | 2015-07-06 | ||
| US201562269060P | 2015-12-17 | 2015-12-17 | |
| US62/269,060 | 2015-12-17 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018500585A Division JP6430060B2 (ja) | 2015-07-06 | 2016-06-30 | Ｃｏｔモジュレーターおよびその使用方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019137759A Division JP6906021B2 (ja) | 2015-07-06 | 2019-07-26 | Ｃｏｔモジュレーターおよびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018193405A JP2018193405A (ja) | 2018-12-06 |
| JP2018193405A5 true JP2018193405A5 (OSRAM) | 2019-09-05 |
| JP6781221B2 JP6781221B2 (ja) | 2020-11-04 |
Family
ID=56411943
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018500585A Active JP6430060B2 (ja) | 2015-07-06 | 2016-06-30 | Ｃｏｔモジュレーターおよびその使用方法 |
| JP2018171794A Active JP6781221B2 (ja) | 2015-07-06 | 2018-09-13 | Ｃｏｔモジュレーターおよびその使用方法 |
| JP2019137759A Active JP6906021B2 (ja) | 2015-07-06 | 2019-07-26 | Ｃｏｔモジュレーターおよびその使用方法 |
| JP2020208330A Active JP7138155B2 (ja) | 2015-07-06 | 2020-12-16 | Ｃｏｔモジュレーターおよびその使用方法 |
| JP2022065168A Withdrawn JP2022082816A (ja) | 2015-07-06 | 2022-04-11 | Ｃｏｔモジュレーターおよびその使用方法 |
| JP2024081151A Withdrawn JP2024100865A (ja) | 2015-07-06 | 2024-05-17 | Ｃｏｔモジュレーターおよびその使用方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018500585A Active JP6430060B2 (ja) | 2015-07-06 | 2016-06-30 | Ｃｏｔモジュレーターおよびその使用方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019137759A Active JP6906021B2 (ja) | 2015-07-06 | 2019-07-26 | Ｃｏｔモジュレーターおよびその使用方法 |
| JP2020208330A Active JP7138155B2 (ja) | 2015-07-06 | 2020-12-16 | Ｃｏｔモジュレーターおよびその使用方法 |
| JP2022065168A Withdrawn JP2022082816A (ja) | 2015-07-06 | 2022-04-11 | Ｃｏｔモジュレーターおよびその使用方法 |
| JP2024081151A Withdrawn JP2024100865A (ja) | 2015-07-06 | 2024-05-17 | Ｃｏｔモジュレーターおよびその使用方法 |
Country Status (41)
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2553449T3 (es) | 2011-07-06 | 2015-12-09 | Gilead Sciences, Inc. | Compuestos para el tratamiento de VIH |
| US10118890B2 (en) | 2014-10-10 | 2018-11-06 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
| PT3191470T (pt) * | 2015-07-06 | 2019-06-05 | Gilead Sciences Inc | Moduladores de cot e métodos para a sua utilização |
| NZ738538A (en) | 2015-07-06 | 2019-06-28 | Gilead Sciences Inc | 6-amino-quinoline-3-carbonitrils as cot modulators |
| EP3478674B1 (en) | 2016-06-30 | 2020-05-13 | Gilead Sciences, Inc. | 4,6-diaminoquinazolines as cot modulators and methods of use thereof |
| EP3597646B1 (en) * | 2016-08-19 | 2023-06-21 | Gilead Sciences, Inc. | Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection |
| EA036921B1 (ru) * | 2017-02-10 | 2021-01-15 | Джилид Сайэнс, Инк. | Терапевтические соединения, которые можно применять для профилактического или терапевтического лечения инфекции вирусом вич |
| CN108794516A (zh) * | 2017-04-26 | 2018-11-13 | 上海时莱生物技术有限公司 | 硼酸和硼酸酯类化合物及其制备方法和用途 |
| AR112413A1 (es) | 2017-08-17 | 2019-10-23 | Gilead Sciences Inc | Formas sólidas de un inhibidor de la cápside del vih |
| AR112412A1 (es) | 2017-08-17 | 2019-10-23 | Gilead Sciences Inc | Formas de sal de colina de un inhibidor de la cápside del vih |
| WO2019065516A1 (ja) * | 2017-09-26 | 2019-04-04 | 日本曹達株式会社 | キノリン化合物および農園芸用殺菌剤 |
| WO2019161017A1 (en) | 2018-02-15 | 2019-08-22 | Gilead Sciences, Inc. | Pyridine derivatives and their use for treating hiv infection |
| US10696657B2 (en) | 2018-02-16 | 2020-06-30 | Gilead Sciences, Inc. | Methods and intermediates for preparing therapeutic compounds |
| US11760701B2 (en) | 2018-02-27 | 2023-09-19 | The Research Foundation For The State University Of New Yrok | Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same |
| CN110294660B (zh) * | 2018-03-23 | 2021-09-24 | 中国农业大学 | 一种含碳碳三键和/或碳氮三键的不饱和有机化合物的还原氘化方法 |
| CN108658996A (zh) * | 2018-06-25 | 2018-10-16 | 中国药科大学 | 一种氘代Fiduxosin的制备方法 |
| TWI842721B (zh) | 2018-07-16 | 2024-05-21 | 美商基利科學股份有限公司 | 用於治療hiv之蛋白殼抑制劑 |
| TWI770527B (zh) | 2019-06-14 | 2022-07-11 | 美商基利科學股份有限公司 | Cot 調節劑及其使用方法 |
| WO2021028323A1 (en) | 2019-08-09 | 2021-02-18 | Idorsia Pharmaceuticals Ltd | (2-acetamidyl)thio-beta-d-galactopyranoside derivatives |
| JP7612662B2 (ja) | 2019-08-09 | 2025-01-14 | イドルシア・ファーマシューティカルズ・リミテッド | （ヘテロ）アリール－メチル－チオ－ベータ－ｄ－ガラクトピラノシド誘導体 |
| IL289197B1 (en) | 2019-08-15 | 2025-10-01 | Idorsia Pharmaceuticals Ltd | History of 2–hydroxycycloalkane–1–carbamoyl |
| KR102824799B1 (ko) | 2019-08-29 | 2025-06-24 | 이도르시아 파마슈티컬스 리미티드 | 알파-d-갈락토피라노시드 유도체 |
| US11807625B2 (en) | 2019-11-26 | 2023-11-07 | Gilead Sciences, Inc. | Capsid inhibitors for the prevention of HIV |
| KR20220161438A (ko) * | 2020-03-30 | 2022-12-06 | 길리애드 사이언시즈, 인코포레이티드 | Cot 억제제 화합물, (S)-6-(((1-(바이사이클로[1.1.1]펜탄-1-일)-1H-1,2,3-트라이아졸-4-일)2-메틸-1-옥소-1,2-다이하이드로아이소퀴놀린-5-일)메틸)))아미노8-클로로-(네오펜틸아미노)퀴놀린-3-카르보니트릴의 고체 형태 |
| WO2021202688A1 (en) * | 2020-04-02 | 2021-10-07 | Gilead Sciences, Inc. | Process for preparing a cot inhibitor compound |
| TW202502766A (zh) | 2020-06-25 | 2025-01-16 | 美商基利科學股份有限公司 | 用於治療hiv之蛋白殼抑制劑 |
| KR20230083301A (ko) | 2020-10-06 | 2023-06-09 | 이도르시아 파마슈티컬스 리미티드 | 알파-d-갈락토피라노사이드의 스피로 유도체 |
| CA3197095A1 (en) | 2020-11-02 | 2022-05-05 | Martin Bolli | Galectin-3 inhibiting 2-hydroxycycloalkane-1 -carbamoyl derivatives |
| CN116806219A (zh) | 2021-02-09 | 2023-09-26 | 爱杜西亚药品有限公司 | 羟基杂环烷-氨甲酰基衍生物 |
| HUE072194T2 (hu) | 2021-03-03 | 2025-10-28 | Idorsia Pharmaceuticals Ltd | Triazolil-metil-szubsztituált alfa-D-galaktopiranozid származékok |
| TW202304435A (zh) | 2021-06-04 | 2023-02-01 | 美商基利科學股份有限公司 | 治療ｎａｓｈ之方法 |
| AU2022289728A1 (en) * | 2021-06-11 | 2023-11-16 | Neuronascent, Inc. | Methods and compositions for lipid formulation of lipophilic small molecule therapies of the heterocyclic type |
| CA3235937A1 (en) | 2021-12-03 | 2023-06-08 | Gilead Sciences, Inc. | Therapeutic compounds for hiv virus infection |
| CN118369316A (zh) | 2021-12-03 | 2024-07-19 | 吉利德科学公司 | Hiv病毒感染的治疗性化合物 |
| JP7765637B2 (ja) | 2021-12-03 | 2025-11-06 | ギリアード サイエンシーズ， インコーポレイテッド | Ｈｉｖウイルス感染症のための治療化合物 |
| WO2024245157A1 (zh) * | 2023-05-30 | 2024-12-05 | 浙江星浩澎博医药有限公司 | 氮杂喹啉环衍生物 |
| WO2024249983A1 (en) * | 2023-06-02 | 2024-12-05 | Westol, Llc | 2,8-dihydroxyquinoline glucuronide derivatives with enhanced properties for use as anticancer, antiviral, antimicrobial, and other therapeutic applications |
| WO2025020886A1 (zh) * | 2023-07-27 | 2025-01-30 | 浙江星浩澎博医药有限公司 | 氮杂喹唑啉环衍生物及其用途 |
| KR102732584B1 (ko) | 2024-03-28 | 2024-11-21 | (주)신한티이씨 | 전기 배전반의 화재 위험 감지 및 진압용 소화 장치 |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3930837A (en) | 1971-12-31 | 1976-01-06 | Ici Australia Limited | 3-chloro-5-acetamidaisoquinoline as a herbicide |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| NL7800191A (nl) | 1977-01-10 | 1978-07-12 | Ciba Geigy | Anthelmintisch preparaat. |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| JP2634438B2 (ja) | 1988-07-26 | 1997-07-23 | 三井東圧化学株式会社 | 不斉ビスオキサゾリルピリジン誘導体およびその製造方法 |
| DE4014171A1 (de) | 1990-05-03 | 1991-11-07 | Basf Ag | Cyanochinolinverbindungen |
| GB9310700D0 (en) | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Novel composition |
| UA73073C2 (uk) * | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
| KR20010022781A (ko) | 1997-08-28 | 2001-03-26 | 도쿠시마 히데이치 | 시아노아크릴레이트 화합물을 함유하는 공업용 항균·항진균제, 살조제(殺藻劑) 및 생물 부착 방지제 |
| EP1097158B1 (en) | 1998-07-10 | 2006-01-25 | Massachusetts Institute Of Technology | Ligands for metals and metal-catalyzed processes |
| PT2253620E (pt) | 1998-09-29 | 2014-04-15 | Wyeth Holdings Llc | 3-cianoquinolinas substituídas como inibidores de proteínas tirosinas quinases |
| MXPA04008999A (es) | 2002-03-20 | 2004-12-07 | Squibb Bristol Myers Co | Profarmacos de fosfato de fluorooxindoles. |
| ATE381334T1 (de) | 2003-03-03 | 2008-01-15 | Hoffmann La Roche | 2,5-substituiertetetrahydroisochinoline zur verwendung als 5-ht6 modulatoren |
| JP2007502819A (ja) | 2003-08-19 | 2007-02-15 | ワイス・ホールディングズ・コーポレイション | ４−アミノ−３−キノリンカルボニトリルの調製方法 |
| US7399865B2 (en) | 2003-09-15 | 2008-07-15 | Wyeth | Protein tyrosine kinase enzyme inhibitors |
| TW200529846A (en) * | 2004-02-20 | 2005-09-16 | Wyeth Corp | 3-quinolinecarbonitrile protein kinase inhibitors |
| GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| AU2006247315A1 (en) * | 2005-05-18 | 2006-11-23 | Wyeth | 4, 6-diamino-[1,7] naphthyridine-3-carbonitrile inhibitors of Tpl2 kinase and methods of making and using the same |
| WO2006124692A2 (en) | 2005-05-18 | 2006-11-23 | Wyeth | 3-cyanoquinoline inhibitors of tpl2 kinase and methods of making and using the same |
| BRPI0617884A2 (pt) | 2005-10-28 | 2011-08-09 | Abbott Lab | derivados de indazol que inibem receptor trpv1 |
| US8008481B2 (en) | 2006-03-31 | 2011-08-30 | Ericsson Anna M | Indazole compounds |
| DK2086960T3 (da) | 2006-11-09 | 2014-06-10 | Probiodrug Ag | Nye inhibitorer af glutaminylcyclase. |
| US8389544B2 (en) | 2007-01-17 | 2013-03-05 | The Hong Kong University Of Science And Technology | Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2 |
| GB0820856D0 (en) | 2008-11-14 | 2008-12-24 | Univ Leuven Kath | Novel inhibitors of flavivirus replication |
| TWI598347B (zh) | 2009-07-13 | 2017-09-11 | 基利科學股份有限公司 | 調節細胞凋亡信號之激酶的抑制劑 |
| GB0922302D0 (en) * | 2009-12-22 | 2010-02-03 | Imp Innovations Ltd | Compounds |
| MX343368B (es) | 2010-03-09 | 2016-11-01 | The Broad Inst Inc * | Metodo de diagnostico y tratamiento de cancer en pacientes que tienen o desarrollan resistencia a una primera terapia de cancer. |
| AU2011264209B2 (en) * | 2010-06-09 | 2014-08-07 | Tianjin Hemay Oncology Pharmaceutical Co., Ltd | Cyanoquinoline derivatives |
| WO2012153796A1 (ja) | 2011-05-10 | 2012-11-15 | 協和発酵キリン株式会社 | ピリミドジアゼピノン化合物 |
| CN103957711A (zh) | 2011-07-04 | 2014-07-30 | 拜耳知识产权有限责任公司 | 取代的异喹啉酮、异喹啉二酮、异喹啉三酮和二氢异喹啉酮或其各自的盐作为活性剂对抗植物非生物胁迫的用途 |
| EP2545964A1 (en) | 2011-07-13 | 2013-01-16 | Phenex Pharmaceuticals AG | Novel FXR (NR1H4) binding and activity modulating compounds |
| PT2772482E (pt) | 2011-10-27 | 2016-06-03 | Taisho Pharmaceutical Co Ltd | Derivados de azole |
| KR102033806B1 (ko) | 2011-11-11 | 2019-10-17 | 길리어드 아폴로, 엘엘씨 | Ａｃｃ 억제제 및 이의 용도 |
| UY34573A (es) | 2012-01-27 | 2013-06-28 | Gilead Sciences Inc | Inhibidor de la quinasa que regula la señal de la apoptosis |
| CN103483363B (zh) | 2012-06-13 | 2016-12-21 | 上海赛迦化工产品有限公司 | 多样性的手性氨基硼酸及其制备方法和应用 |
| WO2014064215A1 (en) | 2012-10-24 | 2014-05-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING β-CELL SURVIVAL |
| CN103408572B (zh) | 2013-07-12 | 2015-12-02 | 上海工程技术大学 | 手性氨基硼酸衍生物及其制备方法和应用 |
| CN105814013A (zh) | 2013-12-12 | 2016-07-27 | 卡利拉制药公司 | 双环烷基化合物及合成 |
| CA2942144C (en) | 2014-03-07 | 2023-08-22 | Kalyra Pharmaceuticals, Inc. | Propellane derivates and synthesis |
| US9701661B2 (en) * | 2014-07-11 | 2017-07-11 | Northwestern University | 2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase |
| JP6833677B2 (ja) | 2014-09-17 | 2021-02-24 | リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー | 二環式化合物 |
| JP2017528471A (ja) | 2014-09-24 | 2017-09-28 | ギリアード サイエンシーズ， インコーポレイテッド | 肝疾患を処置する方法 |
| MA41252A (fr) | 2014-12-23 | 2017-10-31 | Gilead Sciences Inc | Formes solides d'un inhibiteur d'ask 1 |
| ES2842749T3 (es) | 2014-12-23 | 2021-07-14 | Gilead Sciences Inc | Procesos para preparar inhibidores de ASK1 |
| BR112017014341A2 (pt) | 2015-01-09 | 2018-03-27 | Gilead Apollo, Llc | método e sistema para tratamento, estabilização, ou redução da gravidade ou progressão de uma doença de fígado gorduroso não alcoólica, e, composição. |
| EP3852036A1 (en) | 2015-01-16 | 2021-07-21 | 3M Innovative Properties Co. | Systems and methods for selecting grid actions to improve grid outcomes |
| NZ738538A (en) * | 2015-07-06 | 2019-06-28 | Gilead Sciences Inc | 6-amino-quinoline-3-carbonitrils as cot modulators |
| PT3191470T (pt) | 2015-07-06 | 2019-06-05 | Gilead Sciences Inc | Moduladores de cot e métodos para a sua utilização |
| EP3398598B1 (en) | 2015-12-31 | 2022-04-06 | Hitgen Inc. | Sulfonamide derivative and preparation method and use thereof |
| AU2017226267B2 (en) | 2016-03-02 | 2021-06-24 | Gilead Apollo, Llc | Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof |
| US10702503B2 (en) | 2016-06-21 | 2020-07-07 | Phc Holdings Corporation | Catalase inhibitor and method for measuring analyte using catalase inhibitor |
| EP3478674B1 (en) | 2016-06-30 | 2020-05-13 | Gilead Sciences, Inc. | 4,6-diaminoquinazolines as cot modulators and methods of use thereof |
| CN106512014A (zh) | 2016-10-27 | 2017-03-22 | 武汉大学 | 肿瘤进展位点2在治疗脂肪肝和ⅱ型糖尿病中的功能和应用 |
| PL3589636T3 (pl) | 2017-03-03 | 2024-02-19 | Gilead Sciences, Inc. | Sposoby wytwarzania inhibitorów acc i ich form stałych |
| EP4122464B1 (en) | 2017-03-28 | 2024-05-15 | Gilead Sciences, Inc. | Therapeutic combinations for treating liver diseases |
| TW201902478A (zh) | 2017-04-12 | 2019-01-16 | 美商基利科學股份有限公司 | 治療肝臟疾病之方法 |
| US10980810B2 (en) | 2017-10-06 | 2021-04-20 | Gilead Sciences, Inc. | Combination therapy comprising an ACC inhibitor |
| CA3233305A1 (en) | 2019-02-19 | 2020-08-27 | Gilead Sciences, Inc. | Solid forms of fxr agonists |
| WO2020185685A1 (en) | 2019-03-08 | 2020-09-17 | The Regents Of The University Of California | Compositions and methods for treating acne |
| TWI770527B (zh) | 2019-06-14 | 2022-07-11 | 美商基利科學股份有限公司 | Cot 調節劑及其使用方法 |
| AR119594A1 (es) | 2019-08-09 | 2021-12-29 | Gilead Sciences Inc | Derivados de tienopirimidina como inhibidores acc y usos de los mismos |
| KR20220161438A (ko) | 2020-03-30 | 2022-12-06 | 길리애드 사이언시즈, 인코포레이티드 | Cot 억제제 화합물, (S)-6-(((1-(바이사이클로[1.1.1]펜탄-1-일)-1H-1,2,3-트라이아졸-4-일)2-메틸-1-옥소-1,2-다이하이드로아이소퀴놀린-5-일)메틸)))아미노8-클로로-(네오펜틸아미노)퀴놀린-3-카르보니트릴의 고체 형태 |
| WO2021202688A1 (en) | 2020-04-02 | 2021-10-07 | Gilead Sciences, Inc. | Process for preparing a cot inhibitor compound |
| TW202304435A (zh) | 2021-06-04 | 2023-02-01 | 美商基利科學股份有限公司 | 治療ｎａｓｈ之方法 |
-
2016
- 2016-06-30 PT PT16738976T patent/PT3191470T/pt unknown
- 2016-06-30 CR CR20170599A patent/CR20170599A/es unknown
- 2016-06-30 PT PT211623939T patent/PT3896064T/pt unknown
- 2016-06-30 CU CUP2017000172A patent/CU20170172A7/xx unknown
- 2016-06-30 ES ES16738976T patent/ES2734713T3/es active Active
- 2016-06-30 HR HRP20190853TT patent/HRP20190853T1/hr unknown
- 2016-06-30 PT PT181865684T patent/PT3456717T/pt unknown
- 2016-06-30 NZ NZ750707A patent/NZ750707A/en unknown
- 2016-06-30 IL IL274568A patent/IL274568B/en unknown
- 2016-06-30 ME MEP-2019-117A patent/ME03425B/me unknown
- 2016-06-30 LT LTEP16738976.6T patent/LT3191470T/lt unknown
- 2016-06-30 PE PE2017002804A patent/PE20180462A1/es unknown
- 2016-06-30 KR KR1020187003221A patent/KR101974793B1/ko active Active
- 2016-06-30 PL PL18186568T patent/PL3456717T3/pl unknown
- 2016-06-30 CA CA2971640A patent/CA2971640C/en active Active
- 2016-06-30 CN CN202411260421.8A patent/CN119143730A/zh active Pending
- 2016-06-30 MY MYPI2018700007A patent/MY196173A/en unknown
- 2016-06-30 HU HUE16738976A patent/HUE043310T2/hu unknown
- 2016-06-30 SI SI201630202T patent/SI3191470T1/sl unknown
- 2016-06-30 MX MX2017004737A patent/MX370984B/es active IP Right Grant
- 2016-06-30 AU AU2016290820A patent/AU2016290820B2/en active Active
- 2016-06-30 SI SI201631907T patent/SI3896064T1/sl unknown
- 2016-06-30 SM SM20190244T patent/SMT201900244T1/it unknown
- 2016-06-30 KR KR1020247000058A patent/KR20240008398A/ko not_active Ceased
- 2016-06-30 RS RS20190498A patent/RS58639B1/sr unknown
- 2016-06-30 EA EA201792613A patent/EA036788B1/ru unknown
- 2016-06-30 CN CN201680050602.5A patent/CN107922390B/zh active Active
- 2016-06-30 SI SI201631197T patent/SI3456717T1/sl unknown
- 2016-06-30 SG SG11201702041PA patent/SG11201702041PA/en unknown
- 2016-06-30 EP EP21162393.9A patent/EP3896064B1/en active Active
- 2016-06-30 KR KR1020227031078A patent/KR20220129667A/ko not_active Ceased
- 2016-06-30 MA MA39422A patent/MA39422B1/fr unknown
- 2016-06-30 NZ NZ738525A patent/NZ738525A/en unknown
- 2016-06-30 EP EP16738976.6A patent/EP3191470B1/en active Active
- 2016-06-30 WO PCT/US2016/040520 patent/WO2017007689A1/en not_active Ceased
- 2016-06-30 PL PL21162393.9T patent/PL3896064T3/pl unknown
- 2016-06-30 JP JP2018500585A patent/JP6430060B2/ja active Active
- 2016-06-30 EP EP18186568.4A patent/EP3456717B1/en active Active
- 2016-06-30 CN CN202210008753.1A patent/CN114380799B/zh active Active
- 2016-06-30 IL IL293770A patent/IL293770B2/en unknown
- 2016-06-30 KR KR1020197011792A patent/KR102073641B1/ko active Active
- 2016-06-30 PL PL16738976T patent/PL3191470T3/pl unknown
- 2016-06-30 ES ES18186568T patent/ES2872076T3/es active Active
- 2016-06-30 EP EP25176778.6A patent/EP4613332A3/en active Pending
- 2016-06-30 US US15/199,534 patent/US20170008905A1/en not_active Abandoned
- 2016-06-30 CN CN201910292757.5A patent/CN109879859B/zh active Active
- 2016-06-30 UA UAA201712984A patent/UA123010C2/uk unknown
- 2016-06-30 DK DK16738976.6T patent/DK3191470T3/en active
- 2016-06-30 KR KR1020207002878A patent/KR102443575B1/ko active Active
- 2016-06-30 ES ES21162393T patent/ES3034100T3/es active Active
- 2016-07-04 BR BR102016015656-4A patent/BR102016015656B1/pt active IP Right Grant
- 2016-07-05 TW TW105121281A patent/TWI634112B/zh active
- 2016-07-05 TW TW107117905A patent/TWI699361B/zh active
- 2016-07-05 TW TW109122003A patent/TWI748539B/zh active
- 2016-07-06 UY UY0001036771A patent/UY36771A/es not_active Application Discontinuation
-
2017
- 2017-02-09 US US15/429,086 patent/US9878995B2/en active Active
- 2017-04-18 SA SA517381350A patent/SA517381350B1/ar unknown
- 2017-12-20 IL IL256433A patent/IL256433B/en active IP Right Grant
- 2017-12-22 CL CL2017003356A patent/CL2017003356A1/es unknown
- 2017-12-22 CO CONC2017/0013351A patent/CO2017013351A2/es unknown
- 2017-12-22 SV SV2017005605A patent/SV2017005605A/es unknown
- 2017-12-22 EC ECIEPI201784635A patent/ECSP17084635A/es unknown
- 2017-12-26 DO DO2017000311A patent/DOP2017000311A/es unknown
-
2018
- 2018-01-03 PH PH12018500031A patent/PH12018500031B1/en unknown
- 2018-02-07 US US15/891,163 patent/US20180237455A1/en not_active Abandoned
- 2018-09-13 JP JP2018171794A patent/JP6781221B2/ja active Active
-
2019
- 2019-04-23 US US16/391,673 patent/US20190248807A1/en not_active Abandoned
- 2019-05-03 AU AU2019203122A patent/AU2019203122B2/en active Active
- 2019-05-20 CY CY20191100535T patent/CY1121750T1/el unknown
- 2019-05-29 IL IL266995A patent/IL266995B/en active IP Right Grant
- 2019-07-26 JP JP2019137759A patent/JP6906021B2/ja active Active
- 2019-12-17 US US16/717,074 patent/US11066414B2/en active Active
-
2020
- 2020-09-06 PH PH12020551397A patent/PH12020551397A1/en unknown
- 2020-10-20 AU AU2020257055A patent/AU2020257055B2/en active Active
- 2020-12-16 JP JP2020208330A patent/JP7138155B2/ja active Active
-
2021
- 2021-05-11 US US17/317,041 patent/US11905299B2/en active Active
-
2022
- 2022-04-11 JP JP2022065168A patent/JP2022082816A/ja not_active Withdrawn
- 2022-06-10 AU AU2022204050A patent/AU2022204050B2/en active Active
-
2023
- 2023-12-11 US US18/534,800 patent/US20240254137A1/en not_active Abandoned
-
2024
- 2024-05-17 JP JP2024081151A patent/JP2024100865A/ja not_active Withdrawn
- 2024-07-17 AU AU2024204902A patent/AU2024204902A1/en not_active Abandoned
-
2025
- 2025-04-14 US US19/177,702 patent/US20250346609A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018193405A5 (OSRAM) | ||
| JP2019048806A5 (OSRAM) | ||
| JP2010513494A5 (OSRAM) | ||
| JP2015518892A5 (OSRAM) | ||
| JP2020511461A5 (OSRAM) | ||
| JP2017501197A5 (OSRAM) | ||
| JP2015506943A5 (OSRAM) | ||
| CN103764649B (zh) | 通过苯并噁嗪酮与胺反应制备四唑取代的邻氨基苯甲酸二酰胺衍生物的方法 | |
| JP2015181191A5 (OSRAM) | ||
| JP2010503694A5 (OSRAM) | ||
| JP2017523168A (ja) | ３−（３−クロロ−１ｈ−ピラゾール−１−イル）ピリジンの製造方法 | |
| JP5827407B2 (ja) | ４−［５−（ピリジン−４−イル）−１ｈ−１，２，４−トリアゾール−３−イル］ピリジン−２−カルボニトリルの製造方法および中間体 | |
| JP2015129106A5 (OSRAM) | ||
| JP2017515919A5 (OSRAM) | ||
| JP2019505532A5 (OSRAM) | ||
| JP2015524806A5 (OSRAM) | ||
| JP2016539168A5 (OSRAM) | ||
| JP2013241421A5 (OSRAM) | ||
| JP2018506541A5 (OSRAM) | ||
| JP2018009003A5 (OSRAM) | ||
| JP2017533926A5 (OSRAM) | ||
| JP2018535294A5 (OSRAM) | ||
| TWI832015B (zh) | 酪胺酸激酶抑制物之合成 | |
| JP2020506879A5 (OSRAM) | ||
| JP2018509421A5 (OSRAM) |